Commentary on Bowles and Shea: Further perspectives and clinical implications of ingestion-time differences in the efficacy of blood pressure-lowering medications - 18/09/21
Doi : 10.1016/j.smrv.2021.101540
Michael H. Smolensky
Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX, 78712-0238, USA
Ramón C. Hermida ⁎ 
Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX, 78712-0238, USA
Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Information and Communication Technologies (atlanTTic), University of Vigo, Vigo, 36310, Spain
∗Corresponding author. Bioengineering & Chronobiology Labs, Atlantic Research Center for Information and Communication Technologies (atlanTTic), E.I. Telecomunicación, Campus Universitario, Vigo (Pontevedra) 36310, Spain.Bioengineering & Chronobiology LabsAtlantic Research Center for Information and Communication Technologies (atlanTTic)E.I. TelecomunicaciónCampus UniversitarioVigo (Pontevedra)36310Spain
Le texte complet de cet article est disponible en PDF.
© 2021
Elsevier Ltd. Tous droits réservés.
Vol 59
Article 101540- octobre 2021 Retour au numéro
Article précédent
- Should we use the multidimensional model of sleep health to assess the outcomes of sleep health promotion interventions? A commentary on: “Do sleep interventions change sleep duration in children aged 0–5 years?” By Taylor et al.
- Reut Gruber
- Reply to Smolensky and Hermida: The potential role of internal circadian time in tailored anti-hypertensive medication dosing
- Nicole P. Bowles, Steven A. Shea
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?